VRPX logo

Virpax Pharmaceuticals (VRPX) Cash From Financing

Annual CFF

$9.08 M
+$9.08 M+100.00%

December 1, 2024


Summary


Performance

VRPX Cash From Financing Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

High & Low

Earnings dates

OtherVRPXcash flowmetrics:

Quarterly CFF

$4.37 M
+$1.75 M+66.93%

December 1, 2024


Summary


Performance

VRPX Quarterly CFF Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

High & Low

Earnings dates

OtherVRPXcash flowmetrics:

TTM CFF

$9.08 M
+$4.37 M+92.55%

December 1, 2024


Summary


Performance

VRPX TTM CFF Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

High & Low

Earnings dates

OtherVRPXcash flowmetrics:

Cash From Financing Formula

CFF = Cash Inflows from Financing Activities − Cash Outflows from Financing Activities

VRPX Cash From Financing Trends

PeriodPeriodAnnualAnnualQuarterlyQuarterlyTTMTTM
1 y1 year+100.0%0.0%0.0%
3 y3 years-82.3%+8478.6%-82.3%
5 y5 years+707.5%-87.9%-82.3%

VRPX Cash From Financing Highs & Lows

PeriodPeriodAnnual vs highAnnual vs highAnnual vs lowAnnual vs lowQuarter. vs highQuarter. vs highQuarter. vs lowQuarter. vs lowTTM vs highTTM vs highTTM vs lowTTM vs low
3 y3-year-82.3%-100.0%at high-100.0%-82.3%-100.0%
5 y5-year-82.3%-100.0%-87.9%+8678.6%-82.3%-100.0%
alltimeall time-82.3%-100.0%-87.9%+8678.6%-82.3%-100.0%

Virpax Pharmaceuticals Cash From Financing History

DateAnnualQuarterlyTTM
Dec 2024
$9.08 M(>+9900.0%)
$4.37 M(+66.9%)
$9.08 M(+92.5%)
Sep 2024
-
$2.62 M(+58.7%)
$4.72 M(+124.4%)
Jun 2024
-
$1.65 M(+263.0%)
$2.10 M(+363.0%)
Mar 2024
-
$454.00 K(>+9900.0%)
$454.00 K(>+9900.0%)
Dec 2023
$0.00(-100.0%)
$0.00(0.0%)
$0.00(0.0%)
Sep 2023
-
$0.00(0.0%)
$0.00(0.0%)
Jun 2023
-
$0.00(0.0%)
$0.00(0.0%)
Mar 2023
-
$0.00(-100.0%)
$0.00(-100.0%)
Dec 2021
$51.33 M
$50.90 K(-99.9%)
$51.33 M(+0.2%)
DateAnnualQuarterlyTTM
Sep 2021
-
$35.99 M(>+9900.0%)
$51.23 M(+225.8%)
Jun 2021
-
$0.00(-100.0%)
$15.72 M(-3.3%)
Mar 2021
-
$15.29 M(<-9900.0%)
$16.26 M(+1063.2%)
Dec 2020
$1.40 M(+24.3%)
-$50.90 K(-110.5%)
$1.40 M(-3.5%)
Sep 2020
-
$483.00 K(-10.7%)
$1.45 M(+50.0%)
Jun 2020
-
$541.00 K(+27.3%)
$966.00 K(+127.3%)
Mar 2020
-
$425.00 K
$425.00 K
Dec 2019
$1.13 M(-32.8%)
-
-
Dec 2018
$1.67 M
-
-

FAQ

  • What is Virpax Pharmaceuticals annual cash flow from financing activities?
  • What is the all time high annual CFF for Virpax Pharmaceuticals?
  • What is Virpax Pharmaceuticals annual CFF year-on-year change?
  • What is Virpax Pharmaceuticals quarterly cash flow from financing activities?
  • What is the all time high quarterly CFF for Virpax Pharmaceuticals?
  • What is Virpax Pharmaceuticals quarterly CFF year-on-year change?
  • What is Virpax Pharmaceuticals TTM cash flow from financing activities?
  • What is the all time high TTM CFF for Virpax Pharmaceuticals?
  • What is Virpax Pharmaceuticals TTM CFF year-on-year change?

What is Virpax Pharmaceuticals annual cash flow from financing activities?

The current annual CFF of VRPX is $9.08 M

What is the all time high annual CFF for Virpax Pharmaceuticals?

Virpax Pharmaceuticals all-time high annual cash flow from financing activities is $51.33 M

What is Virpax Pharmaceuticals annual CFF year-on-year change?

Over the past year, VRPX annual cash flow from financing activities has changed by +$9.08 M (+100.00%)

What is Virpax Pharmaceuticals quarterly cash flow from financing activities?

The current quarterly CFF of VRPX is $4.37 M

What is the all time high quarterly CFF for Virpax Pharmaceuticals?

Virpax Pharmaceuticals all-time high quarterly cash flow from financing activities is $35.99 M

What is Virpax Pharmaceuticals quarterly CFF year-on-year change?

Over the past year, VRPX quarterly cash flow from financing activities has changed by $0.00 (0.00%)

What is Virpax Pharmaceuticals TTM cash flow from financing activities?

The current TTM CFF of VRPX is $9.08 M

What is the all time high TTM CFF for Virpax Pharmaceuticals?

Virpax Pharmaceuticals all-time high TTM cash flow from financing activities is $51.33 M

What is Virpax Pharmaceuticals TTM CFF year-on-year change?

Over the past year, VRPX TTM cash flow from financing activities has changed by $0.00 (0.00%)